skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

About Daniel

+11 year(s) experience

Daniel Chancellor - Pharmaintelligence
Director Daniel Chancellor develops and leads Informa Pharma Intelligence’s thought leadership program, producing materials that help clients across a range of hot topics in the biopharma industry.


Daniel has a decade of experience as an analyst in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. He covers topics such as COVID-19, immuno-oncology, tumour-agnostic drug development, artificial intelligence, and mergers and acquisitions (M&A), and regularly participates in webinars, conferences, and other speaking arrangements.

Daniel is featured across leading publications such as Nature Reviews Drug Discovery, Fortune, Scientific American, Scrip, In Vivo and Vice. 

Prior to joining Informa, Daniel worked as a medicinal chemist at the U.K. biotech company Summit Therapeutics and graduated with First Class Honours in Natural Sciences from the University of Bath.

Analyst Articles

Articles by Daniel